- Trials with a EudraCT protocol (113)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
113 result(s) found for: Generation effect.
Displaying page 1 of 6.
EudraCT Number: 2016-001335-12 | Sponsor Protocol Number: D5160C00030 | Start Date*: 2016-05-12 |
Sponsor Name:Hellenic Oncology Research Group | ||
Full Title: A longitudinal study evaluating molecular changes associated with resistance to first and third (AZD9291) generation EGFR TKIs in patients with EGFR mutant NSCLC using "liquid biopsy" | ||
Medical condition: Patients with NSCLC | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002263-96 | Sponsor Protocol Number: 39486 | Start Date*: 2012-07-11 |
Sponsor Name:MUMC | ||
Full Title: dabigatran and rivaroxaban: prediction of anticoagulant effect | ||
Medical condition: non valvular atrial fibrillation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001212-29 | Sponsor Protocol Number: Prot-0824-2019 | Start Date*: 2020-08-26 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital, Henrik Birn | ||||||||||||||||||
Full Title: Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome | ||||||||||||||||||
Medical condition: Nephrotic syndrome is defined as severe proteinuria (> 3.5 g / day), edema and hypoalbuminemia. It is conditioned by a defect in the kidney's glomerular filtration barrier, resulting in the loss of... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002854-66 | Sponsor Protocol Number: | Start Date*: 2013-10-08 |
Sponsor Name:University Hospital Southampton NHS Foundation Trust | ||
Full Title: Southampton Pregnancy Intervention for the Next Generation - a randomised controlled trial of vitamin D and nurse support in improving the diet and body composition of young women and their children. | ||
Medical condition: We are not investigating a medical condition as such, but the effect of vitamin D on offspring body composition and bone mass, which are risk factors for later ill health. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002068-27 | Sponsor Protocol Number: 500 | Start Date*: 2006-04-20 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Prevention of venous thrombosis in cancer patients: A prospective, randomized, double-blind study comparing two different dosages of low-molecular weight heparin | ||
Medical condition: cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002204-24 | Sponsor Protocol Number: 1160.203 | Start Date*: 2014-12-17 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: REVERSAL OF ANTICOAGULANT EFFECT OF DABIGATRAN® BY PROTHROMBIN COMPLEX CONCENTRATE (BERIPLEX®) ASSESSED WITH A NOVEL METHOD OF BLOOD LOSS MEASUREMENT | ||
Medical condition: Healthy male volunteers. Study assessing the effect of a single 50IU/Kg dose of Beriplex on the anticoagulant effect of Dabigatran. This is of interest when rapid reversal of its effect is mandate... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000904-41 | Sponsor Protocol Number: XRP0673A/2002 | Start Date*: 2004-10-14 |
Sponsor Name:Aventis Pharmaceuticals Inc. | ||
Full Title: A multinational, randomized, double-blind, double-dummy, exploratory, parallel-group, dose-ranging phase II study to evaluate the pharmacodynamics, the safety and tolerability, and the pharmacokine... | ||
Medical condition: Patients with coronary heart disease who will be undergoing non-urgent Percutaneous Coronary Intervention (PCI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) ES (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000098-65 | Sponsor Protocol Number: 09012313 | Start Date*: 2013-09-13 |
Sponsor Name:University of Tromsø | ||
Full Title: Treatment of Axial Spondyloarthritis with reduced doses of NSAIDs: Application of pharmacotherapeutic conditioning in clinical practice. | ||
Medical condition: Axial Spondyloarthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002082-38 | Sponsor Protocol Number: RG_11-123 | Start Date*: 2012-04-16 |
Sponsor Name:University of Birmingham | ||
Full Title: A study of the effects of Simvastatin on neutrophil function in elderly subjects | ||
Medical condition: We are investigating the effects of Simvastatin 80mg on neutrophil function (using in vitro studies of neutrophil function), in healthy elderly subjects as there is evidence to suggest that Simvast... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002094-22 | Sponsor Protocol Number: 2013MM002B | Start Date*: 2013-08-29 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) | |||||||||||||
Full Title: Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease | |||||||||||||
Medical condition: The effect of oestrogen replacement therapy taken either orally or transdermally and observing any likely benefit of both these therapies on the risks Venous thromobembolic events and cardiovascul... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004043-36 | Sponsor Protocol Number: 004:TCELL | Start Date*: 2017-04-28 |
Sponsor Name:Uppsala University | ||
Full Title: CD19-TARGETING 3RD GENERATION CAR T CELLS FOR REFRACTORY B CELL MALIGNANCY – A PHASE II TRIAL | ||
Medical condition: CD19+ B cell lymphoma or leukemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002337-42 | Sponsor Protocol Number: ETOP18-21 | Start Date*: 2023-02-02 |
Sponsor Name:ETOP IBCSG Partners Foundation | ||
Full Title: A multicentre single-arm phase II trial of amivantamab, lazertinib plus bevacizumab in patients with EGFR-mutant advanced NSCLC with progression on previous third generation EGFR TKI | ||
Medical condition: patients with EGFR-mutant advanced NSCLC with progression on previous third generation EGFR TKI | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Trial now transitioned) ES (Ongoing) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000169-17 | Sponsor Protocol Number: D3259C00001 | Start Date*: 2020-12-01 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase 2b Multinational, Randomized, Double-blind, Parallel Group, 24-week Placebo-controlled Study with 28-week Extension to Investigate the Use of Benralizumab in Patients with Chronic Spontaneo... | |||||||||||||
Medical condition: chronic spontaneous urticaria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000833-38 | Sponsor Protocol Number: ISIS329993-CS6 | Start Date*: 2012-06-19 | |||||||||||
Sponsor Name:Isis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2 Study to Assess the Antiarrhythmic and Symptomatic Effect of the Second Generation Antisense Oligonucleotide ISIS 329993 Targeting CRP in Patients with Paroxysmal Atrial Fibrillation | |||||||||||||
Medical condition: Atrial fibrillation (AF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002365-19 | Sponsor Protocol Number: 2 | Start Date*: 2018-08-22 |
Sponsor Name:Line Velling Magnussen | ||
Full Title: Muscle strength and -mass after bariatric surgery - a possible effect of testosterone replacement therapy? Randomized, placebo-controlled and double-blinded study | ||
Medical condition: General aim To investigate the effect and clinical relevance of testosterone therapy combined with exercise and diet counselling in hypogonadal men undergoing bariatric surgery. Objectives To eval... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000709-36 | Sponsor Protocol Number: 15/0947 | Start Date*: 2016-11-23 | ||||||||||||||||||||||||||
Sponsor Name:UCL | ||||||||||||||||||||||||||||
Full Title: Research into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial | ||||||||||||||||||||||||||||
Medical condition: Schizophrenia, delusional disorders, schizoaffective disorder, psychosis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002385-31 | Sponsor Protocol Number: 2015/582 | Start Date*: 2017-08-28 | |||||||||||
Sponsor Name:Professor Peter Humaidan, The Fertility Clinic Skive | |||||||||||||
Full Title: A double-blind, placebo-controlled multicenter trial on the effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003009-31 | Sponsor Protocol Number: HH007 | Start Date*: 2022-12-23 | |||||||||||
Sponsor Name:Zealand University Hospital, dept. of Haematology | |||||||||||||
Full Title: Atorvastatin for patients with Philadelphia-negative chronic myeloproliferative neoplasms - Essential thrombocythemia, polycythemia vera and prefibrotic myelofibrosis | |||||||||||||
Medical condition: Essential thrombocythemia, Polycythemia vera, prefibrotic myelofibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002911-27 | Sponsor Protocol Number: BOC-PR | Start Date*: 2011-09-30 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PARMA | |||||||||||||
Full Title: Effect of boceprevir therapy on HCV-specific T cell responses: perspectives of immune monitoring and immune therapy | |||||||||||||
Medical condition: Chronic active hepatitis C never treated previously with anti-viral terapie | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003862-15 | Sponsor Protocol Number: 2013-601 | Start Date*: 2013-11-19 | |||||||||||
Sponsor Name:Jens Faber | |||||||||||||
Full Title: Liraglutide in Polycystic Ovary Syndrome A randomised, double-blind, placebo-controlled study of the effect of Liraglutide in Polycystic ovary syndrome on risk markers of vascular Thrombosis | |||||||||||||
Medical condition: Polycystic Ovary Syndrome (PCOS), especialy signs of early cardiovascular disease in women with PCOS. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
